Kyung Nam Pharm Co Ltd (053950) - Total Liabilities
Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has total liabilities worth ₩50.62 Billion KRW (≈ $34.30 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Kyung Nam Pharm Co Ltd (053950) equity growth momentum to track the company's year-over-year net asset growth rate.
Kyung Nam Pharm Co Ltd - Total Liabilities Trend (2007–2025)
This chart illustrates how Kyung Nam Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Kyung Nam Pharm Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Kyung Nam Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PTT Global Chemical Public Company Limited
F:GCB
|
Germany | €310.60 Billion |
|
PTT Public Company Limited
F:PTOG
|
Germany | €1.62 Trillion |
|
Ptt PCL
STU:PTOG
|
Germany | €1.67 Trillion |
|
Bluebird Merchant Ventures Ltd
LSE:BMV
|
UK | GBX4.64 Million |
|
Global UAV Technologies Ltd
STU:YAB2
|
Germany | €1.49 Million |
|
Bruush Oral Care Inc.
NASDAQ:BRSHF
|
USA | $6.07 Million |
|
PipeHawk plc
LSE:PIP
|
UK | GBX8.61 Million |
|
Sabien Technology Group Plc
LSE:SNT
|
UK | GBX727.00K |
Liability Composition Analysis (2007–2025)
This chart breaks down Kyung Nam Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Kyung Nam Pharm Co Ltd worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kyung Nam Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kyung Nam Pharm Co Ltd (2007–2025)
The table below shows the annual total liabilities of Kyung Nam Pharm Co Ltd from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩47.33 Billion ≈ $32.08 Million |
-7.85% |
| 2024-12-31 | ₩51.36 Billion ≈ $34.81 Million |
-33.10% |
| 2023-12-31 | ₩76.78 Billion ≈ $52.03 Million |
+72.54% |
| 2022-12-31 | ₩44.50 Billion ≈ $30.16 Million |
-35.78% |
| 2020-12-31 | ₩69.29 Billion ≈ $46.96 Million |
+422.30% |
| 2019-12-31 | ₩13.27 Billion ≈ $8.99 Million |
-45.28% |
| 2018-12-31 | ₩24.24 Billion ≈ $16.43 Million |
-14.49% |
| 2016-12-31 | ₩28.35 Billion ≈ $19.22 Million |
-57.82% |
| 2010-12-31 | ₩67.22 Billion ≈ $45.56 Million |
+7.72% |
| 2009-12-31 | ₩62.41 Billion ≈ $42.29 Million |
+43.46% |
| 2008-12-31 | ₩43.50 Billion ≈ $29.48 Million |
+37.89% |
| 2007-12-31 | ₩31.55 Billion ≈ $21.38 Million |
-- |
About Kyung Nam Pharm Co Ltd
Kyung Nam Pharm Co.,Ltd. manufactures pharmaceuticals. The company offers over-the-counter products, including antipyretics, analgesics, and antiphlogistics; medications for skin diseases and athlete's foot; pain relief patches/creams, antitussives, mucolytic agents, and expectorants; gastro protective agents/digestives; periodontal/gum disease drugs; medications for liver diseases; ear and nose … Read more